Abortive infection: T cells as early, antibody-independent defenders
- 2 April 2026
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 26 (5) , 327-329
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infectionNature Communications, 2025
- Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humansNature Microbiology, 2025
- Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort studyThe Lancet Rheumatology, 2023
- Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion proteinNature Communications, 2022
- Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contactsNature Communications, 2022
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Nature, 2021
- Correlates of protection against SARS-CoV-2 in rhesus macaquesNature, 2020
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19Cell, 2020
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humansNature Medicine, 2012
- HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian womenNature Medicine, 1995